| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 957,173 | 707,836 | 849,554 | 953,500 | | Cost of Revenue | 560,030 | 1,082,420 | 388,607 | 333,108 | | | Gross Profit | 397,143 | (374,584) | 460,947 | 620,392 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,807 | (455,720) | 206,626 | 242,810 | | Non Recurring |
-
| (63,697) |
-
| 10,454 | | Others | 68,511 | 67,446 | 67,383 | 68,794 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 289,825 | 77,387 | 186,938 | 298,334 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,457 | 6,944 | 4,473 | 4,661 | | Earnings Before Interest And Taxes | 292,282 | 84,331 | 191,411 | 302,995 | | Interest Expense | 57,279 | 56,842 | 57,959 | 58,704 | | Income Before Tax | 235,003 | 27,489 | 133,452 | 244,291 | | Income Tax Expense | 100,906 | 11,549 | 44,304 | 89,820 | | Minority Interest |
-
| 267 | (159) | (345) | | | | Net Income From Continuing Ops | 134,097 | 16,207 | 88,989 | 154,126 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 134,097 | 16,207 | 88,989 | 154,126 | | Preferred Stock And Other Adjustments | (172) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $133,925 | $16,207 | $88,989 | $154,126 |
|
0.45% Nasdaq 
0.20%
Income Statement
